4.6 Article

USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis

Shuyan Liu et al.

Summary: Liquid-liquid phase separation is a generic approach to studying the dynamic regulation of phase-separated assemblies and the roles of protein posttranslational modifications. USP42, a deubiquitylase, has been identified to play a pivotal role in nuclear speckle phase separation, mRNA splicing, and cancer cell growth. Inhibition of USP42 presents a novel anticancer strategy by targeting phase separation.

CELL DEATH AND DIFFERENTIATION (2021)

Review Biochemistry & Molecular Biology

The Multifaceted Roles of USP15 in Signal Transduction

Tanuza Das et al.

Summary: This review discusses the important role of deubiquitinase USP15 in various signaling pathways, highlighting its mechanisms in regulating protein stability and signal transduction processes. Understanding the regulatory mechanisms of USP15 can provide important insights into possible disease markers and clinical applications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2

Shourong Wang et al.

Summary: The overexpression of splicing factor USP39 in high-grade serous ovarian carcinoma is associated with poor prognosis and its role in promoting tumor growth and invasion is mediated by transcriptional activation by the oncogene c-MYC. USP39 colocalizes with spliceosome components in nuclear speckles and deletion of USP39 leads to impaired splicing characterized by skipped exons and increased introns. Moreover, USP39 facilitates efficient splicing of HMGA2 and enhances the malignancy of ovarian cancer cells, suggesting it as a potential therapeutic target in ovarian cancer.

CELL DEATH & DISEASE (2021)

Article Cell Biology

The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression

Xiaohong Xia et al.

Summary: The study highlights the importance of deubiquitinase USP15 in preventing ERα degradation and promoting breast cancer progression. Knockdown of USP15 enhances the antitumor activities of tamoxifen on breast cancer cells. These findings provide a new approach to overcoming resistance to endocrine therapy and targeting the USP15-ERα axis for therapeutic strategies on ERα degradation.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET2

Lei-lei Chen et al.

SCIENCE ADVANCES (2020)

Review Oncology

RNA Splicing and Cancer

Eric Wang et al.

TRENDS IN CANCER (2020)

Article Cell Biology

Loss of zinc-finger protein 143 contributes to tumour progression by interleukin-8-CXCR axis in colon cancer

Vikas Verma et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Li Ding et al.

Article Biochemistry & Molecular Biology

The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity

Andrew B. Fielding et al.

ONCOGENE (2018)

Article Multidisciplinary Sciences

USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells

Achuth Padmanabhan et al.

NATURE COMMUNICATIONS (2018)

Article Biochemical Research Methods

HISAT: a fast spliced aligner with low memory requirements

Daehwan Kim et al.

NATURE METHODS (2015)

Article Biochemistry & Molecular Biology

Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage

Daniel F. Comiskey et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Biotechnology & Applied Microbiology

Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology

Vania Goncalves et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Biochemistry & Molecular Biology

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

Pieter J. A. Eichhorn et al.

NATURE MEDICINE (2012)

Article Biochemistry & Molecular Biology

The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation

Olga Anczukow et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)

Article Biochemistry & Molecular Biology

SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control

Shuying Sun et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)

Review Biochemistry & Molecular Biology

The SR protein family of splicing factors: master regulators of gene expression

Jennifer C. Long et al.

BIOCHEMICAL JOURNAL (2009)

Article Biochemistry & Molecular Biology

The COP9 Signalosome Mediates β-Catenin Degradation by Deneddylation and Blocks Adenomatous Polyposis coli Destruction via USP15

Xiaohua Huang et al.

JOURNAL OF MOLECULAR BIOLOGY (2009)

Editorial Material Oncology

Alternative Splicing in Lung Cancer

Ruben Pio et al.

JOURNAL OF THORACIC ONCOLOGY (2009)

Article Multidisciplinary Sciences

Alternative isoform regulation in human tissue transcriptomes

Eric T. Wang et al.

NATURE (2008)

Editorial Material Biochemistry & Molecular Biology

Alternative splicing and disease

Eddo Kim et al.

RNA BIOLOGY (2008)

Article Genetics & Heredity

Insights into the connection between cancer and alternative splicing

Eddo Kim et al.

TRENDS IN GENETICS (2008)

Article Biochemistry & Molecular Biology

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

Rotem Karni et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)

Review Oncology

Alternative splicing: an emerging topic in molecular and clinical oncology

Maria J. Pajares et al.

LANCET ONCOLOGY (2007)

Article Cell Biology

The connection between splicing and cancer

Anabella Srebrow et al.

JOURNAL OF CELL SCIENCE (2006)

Article Biochemistry & Molecular Biology

Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene

C Ghigna et al.

MOLECULAR CELL (2005)

Review Medical Laboratory Technology

Splice variants as cancer biomarkers

BMN Brinkman

CLINICAL BIOCHEMISTRY (2004)

Review Oncology

Aberrant and alternative splicing in cancer

JP Venables

CANCER RESEARCH (2004)